Serum M65 as a biomarker for metastatic renal cell carcinoma.


Yildiz İ. , Sen F., Kilic L. , Keskin S., Duranyildiz D., Bilgin E., ...More

Clinical genitourinary cancer, vol.11, no.3, pp.290-6, 2013 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 11 Issue: 3
  • Publication Date: 2013
  • Doi Number: 10.1016/j.clgc.2013.01.001
  • Title of Journal : Clinical genitourinary cancer
  • Page Numbers: pp.290-6

Abstract

We aimed to investigate the prognostic significance of M30 and M65 which are biomarkers of apoptotic cell death in renal cell cancer (RCC). Serum levels of M30 and M65 were analyzed in 39 consecutively enrolled patients with metastatic RCC and control subjects using enzyme-linked immunosorbent assay (ELISA) kits. We found that high serum M65 levels might predict worse outcome resulting in shorter progression-free survival in RCC.